Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.
2.

Global analysis of Plasmodium falciparum histidine-rich protein-2 (pfhrp2) and pfhrp3 gene deletions using whole-genome sequencing data and meta-analysis.

Sepúlveda N, Phelan J, Diez-Benavente E, Campino S, Clark TG, Hopkins H, Sutherland C, Drakeley CJ, Beshir KB.

Infect Genet Evol. 2018 May 2;62:211-219. doi: 10.1016/j.meegid.2018.04.039. [Epub ahead of print]

PMID:
29729386
3.

Plasmodium-associated changes in human odor attract mosquitoes.

Robinson A, Busula AO, Voets MA, Beshir KB, Caulfield JC, Powers SJ, Verhulst NO, Winskill P, Muwanguzi J, Birkett MA, Smallegange RC, Masiga DK, Mukabana WR, Sauerwein RW, Sutherland CJ, Bousema T, Pickett JA, Takken W, Logan JG, de Boer JG.

Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4209-E4218. doi: 10.1073/pnas.1721610115. Epub 2018 Apr 16.

4.

Plasmodium falciparum parasites with histidine-rich protein 2 (pfhrp2) and pfhrp3 gene deletions in two endemic regions of Kenya.

Beshir KB, Sepúlveda N, Bharmal J, Robinson A, Mwanguzi J, Busula AO, de Boer JG, Sutherland C, Cunningham J, Hopkins H.

Sci Rep. 2017 Nov 7;7(1):14718. doi: 10.1038/s41598-017-15031-2.

5.

Contribution of Plasmodium knowlesi to Multispecies Human Malaria Infections in North Sumatera, Indonesia.

Lubis IND, Wijaya H, Lubis M, Lubis CP, Divis PCS, Beshir KB, Sutherland CJ.

J Infect Dis. 2017 Apr 1;215(7):1148-1155. doi: 10.1093/infdis/jix091.

6.

Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children.

Muwanguzi J, Henriques G, Sawa P, Bousema T, Sutherland CJ, Beshir KB.

Malar J. 2016 Jan 22;15:36. doi: 10.1186/s12936-016-1095-y.

7.

Delayed Onset of Symptoms and Atovaquone-Proguanil Chemoprophylaxis Breakthrough by Plasmodium malariae in the Absence of Mutation at Codon 268 of pmcytb.

Teo BH, Lansdell P, Smith V, Blaze M, Nolder D, Beshir KB, Chiodini PL, Cao J, Färnert A, Sutherland CJ.

PLoS Negl Trop Dis. 2015 Oct 20;9(10):e0004068. doi: 10.1371/journal.pntd.0004068. eCollection 2015.

8.

Directional selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT.

Henriques G, Hallett RL, Beshir KB, Gadalla NB, Johnson RE, Burrow R, van Schalkwyk DA, Sawa P, Omar SA, Clark TG, Bousema T, Sutherland CJ.

J Infect Dis. 2014 Dec 15;210(12):2001-8. doi: 10.1093/infdis/jiu358. Epub 2014 Jul 3.

9.

Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity, clonality and drug resistance markers.

van Schalkwyk DA, Burrow R, Henriques G, Gadalla NB, Beshir KB, Hasford C, Wright SG, Ding XC, Chiodini PL, Sutherland CJ.

Malar J. 2013 Sep 13;12:320. doi: 10.1186/1475-2875-12-320.

10.

Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence.

Beshir KB, Sutherland CJ, Sawa P, Drakeley CJ, Okell L, Mweresa CK, Omar SA, Shekalaghe SA, Kaur H, Ndaro A, Chilongola J, Schallig HD, Sauerwein RW, Hallett RL, Bousema T.

J Infect Dis. 2013 Dec 15;208(12):2017-24. doi: 10.1093/infdis/jit431. Epub 2013 Aug 14.

11.

The polymorphic linker domain of pfmdr1 is associated with resistance-conferring mutations in Plasmodium falciparum populations from East and West Africa.

Okombo J, Zongo I, Gadalla N, Bousema T, Beshir KB, Roper C, Hallett R, Ochola-Oyier LI, Sutherland CJ.

Antimicrob Agents Chemother. 2013 Sep;57(9):4595-8. doi: 10.1128/AAC.00455-13. Epub 2013 Jul 8.

12.

HIV-positive nigerian adults harbor significantly higher serum lumefantrine levels than HIV-negative individuals seven days after treatment for Plasmodium falciparum infection.

Chijioke-Nwauche I, van Wyk A, Nwauche C, Beshir KB, Kaur H, Sutherland CJ.

Antimicrob Agents Chemother. 2013 Sep;57(9):4146-50. doi: 10.1128/AAC.02508-12. Epub 2013 Jun 17.

13.

Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial.

Sawa P, Shekalaghe SA, Drakeley CJ, Sutherland CJ, Mweresa CK, Baidjoe AY, Manjurano A, Kavishe RA, Beshir KB, Yussuf RU, Omar SA, Hermsen CC, Okell L, Schallig HD, Sauerwein RW, Hallett RL, Bousema T.

J Infect Dis. 2013 Jun 1;207(11):1637-45. doi: 10.1093/infdis/jit077. Epub 2013 Mar 6.

PMID:
23468056
14.

Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance.

Beshir KB, Hallett RL, Eziefula AC, Bailey R, Watson J, Wright SG, Chiodini PL, Polley SD, Sutherland CJ.

Malar J. 2010 Nov 5;9:312. doi: 10.1186/1475-2875-9-312.

Supplemental Content

Loading ...
Support Center